Team:KULeuven/Zandbak/Home
From 2008.igem.org
m |
m |
||
Line 36: | Line 36: | ||
$('#kuleuven-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | $('#kuleuven-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | ||
$('#team-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | $('#team-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | ||
+ | $('#bioscenter-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | ||
$('#project-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | $('#project-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | ||
$('#modeling-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | $('#modeling-box > ul').tabs({ fx: { opacity: 'toggle', height: 'toggle'} }); | ||
Line 53: | Line 54: | ||
* Countdown/Number Visitors/... | * Countdown/Number Visitors/... | ||
* Background images... | * Background images... | ||
+ | * ... | ||
+ | |||
+ | Global: | ||
+ | * Breadcrumb navigation? | ||
* ... | * ... | ||
Line 134: | Line 139: | ||
</div> | </div> | ||
<!-- END TEAM BOX --> | <!-- END TEAM BOX --> | ||
+ | |||
+ | <!-- BIOSCENTER BOX --> | ||
+ | <div id="bioscenter-box" class="bioscenter"> | ||
+ | <ul> | ||
+ | <li><a href="#bioscenter-1"><span>On Synthetic Biology</span></a></li> | ||
+ | <li><a href="#bioscenter-2"><span>On IGEM</span></a></li> | ||
+ | </ul> | ||
+ | |||
+ | <div id="bioscenter-1"> | ||
+ | Synthetic biology is a new challenge in biosciences. It combines biology and engineering principles to design and build new biological functions and systems. Examples are abound: cancer cell invading bacteria, microbes that take pictures, antimalarial drug producers,... The advantage of using living systems for these purposes is that, once they are designed and built, they are self-reproducible. The challenge, however lies exactly within the design and construction: making biological circuits and devices as robust and predictive as their electrical counterparts. | ||
+ | <a href="http://www.kuleuven.be/bioscenter/igem/?go=syntheticbiology">Read the entire page</a> | ||
+ | </div> | ||
+ | |||
+ | <div id="bioscenter-2"> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | <!-- END BIOSCENTER BOX --> | ||
<!-- PROJECT BOX --> | <!-- PROJECT BOX --> | ||
Line 190: | Line 214: | ||
<!-- SIDEBAR CONTENT --> | <!-- SIDEBAR CONTENT --> | ||
<div id="kul-sidebar-content"> | <div id="kul-sidebar-content"> | ||
+ | |||
<!-- FUN STUFF --> | <!-- FUN STUFF --> | ||
- | <div class="sidebox"> | + | <div class="sidebox external"> |
<h3>Fun Stuff</h3> | <h3>Fun Stuff</h3> | ||
</div> | </div> |
Revision as of 10:05, 14 August 2008
Work to be done:
- Fill up the boxes with text and content!!
- Fun stuff
- IE fixes to tab areas!... DONE (Reminder: .ui-tabs-nav .ui-tabs-selected a had position: relative; not good!)
- Team image map: http://drupal.org/project/jq_maphilight
- Dilbert
- Countdown/Number Visitors/...
- Background images...
- ...
Global:
- Breadcrumb navigation?
- ...
Wellcome to the KULeuven 2008 iGEM team page!
The 2008 iGEM team of the Katholieke Universiteit Leuven works on a bacterial drug delivery system, for instance for the production of a peptide such as vasoactive intestinal peptide as a potential treatment for Crohn's disease. The bacterial drug delivery system will have several advantages over classical drugs. These are (a) the bacterium will produce the exact amount of drug necessary for each individual by means of a feedback control mechanism, (b) the bacterium will die upon a long symptomless period and (c) a possible development towards drugs being taken up in the bloodstream.
...
This is the first kuleuven ... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing...